AstraZeneca, Bayer, Eli Lilly and Merck are just a few of the names that may join a bidding war for the cancer drug maker, analysts say.
Oil giant Total continues its foray into renewable energy.
As the health insurer awaits regulatory approval for its $37 billion megadeal with rival Aetna, it continues to suffer losses from its participation in Obamacare.
The suitor is urging Chicago-based Tribune's shareholders to vote against their board to send a message that the two sides should discuss a combination.
The hefty payout comes as Paramount and Lions Gate seek deal partners.
The troubled internet company's unusually high level of director churn raises concerns about oversight. And its newest board members may not help.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.